Geneception
China · Founded 2019 · $150.0M raised
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Total Funding
- $150.0M
- Last Round
- $150.0M Series AJan 2019
- Rounds
- 1
About
Gene and cell therapy company; rebranded as Skyline Therapeutics in 2020, focused on innovative gene therapy development.
Summary
Geneception is a Biotech company based in China, founded in 2019. It has raised $150.0M in total across 1 round, most recently a $150.0M Series A round in Jan 2019. Investors include Hillhouse Capital, Sequoia Capital and ARCH Venture Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2019
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...